C4 Therapeutics (CCCC) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free CCCC Stock Alerts $6.80 +0.35 (+5.43%) (As of 05/9/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineC4 Therapeutics: Hold Rating Maintained Amidst Encouraging Drug Progress and Stable Financialsmarkets.businessinsider.com - May 9 at 7:39 PMKey Takeaways From C4 Therapeutics Analyst Ratingsmarkets.businessinsider.com - May 9 at 7:39 PMC4 Therapeutics (NASDAQ:CCCC) Given New $8.00 Price Target at Wells Fargo & Companymarketbeat.com - May 9 at 12:28 PMC4 Therapeutics, Inc. (NASDAQ:CCCC) Given Consensus Recommendation of "Moderate Buy" by Brokeragesamericanbankingnews.com - May 9 at 4:06 AMCCCC Stock Earnings: C4 Therapeutics Misses EPS, Misses Revenue for Q1 2024investorplace.com - May 8 at 3:17 PMC4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlightsglobenewswire.com - May 8 at 7:00 AMC4 Therapeutics, Inc.: C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)finanznachrichten.de - April 30 at 6:27 PMC4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - April 29 at 4:01 PMC4 Therapeutics, Inc. (NASDAQ:CCCC) Receives Consensus Rating of "Moderate Buy" from Brokeragesmarketbeat.com - April 14 at 4:39 AMC4 Therapeutics, Inc. (NASDAQ:CCCC) Short Interest Up 73.0% in Marchmarketbeat.com - April 11 at 6:49 PMArvinas And Novartis Partnering On Prostate Cancer Protein Degrader Is A Win-Win Situationseekingalpha.com - April 11 at 5:38 PMC4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology Forumglobenewswire.com - April 9 at 7:00 AMC4 Dips on Release of Datamsn.com - April 8 at 2:05 PMC4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024finance.yahoo.com - April 8 at 8:14 AMC4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024globenewswire.com - April 8 at 8:00 AMPublic Employees Retirement System of Ohio Lowers Position in C4 Therapeutics, Inc. (NASDAQ:CCCC)marketbeat.com - March 29 at 4:19 AMC4 Therapeutics, Inc. (NASDAQ:CCCC) Sees Significant Increase in Short Interestmarketbeat.com - March 28 at 6:00 PMC4 Therapeutics (NASDAQ:CCCC) Shares Down 2% marketbeat.com - March 28 at 4:33 PMHere’s Why Meridian Small Cap Growth Fund Trimmed C4 Therapeutics (CCCC)finance.yahoo.com - March 28 at 6:58 AMC4 Therapeutics (NASDAQ:CCCC) Trading Down 3.9%marketbeat.com - March 20 at 1:51 PMC4 Therapeutics (NASDAQ:CCCC) Trading Up 7.3%marketbeat.com - March 19 at 4:48 PMC4 Therapeutics, Inc. (NASDAQ:CCCC) Sees Significant Drop in Short Interestmarketbeat.com - March 18 at 2:22 PMCCCC Mar 2024 17.000 callfinance.yahoo.com - March 16 at 2:31 AMCCCC Mar 2024 10.000 putfinance.yahoo.com - March 16 at 2:31 AMC4 Therapeutics (NASDAQ:CCCC) Stock Price Down 6.8%marketbeat.com - March 14 at 12:47 PMGuru Fundamental Report for CCCCnasdaq.com - March 9 at 3:19 PMC4 Therapeutics, Inc. (NASDAQ:CCCC) Shares Sold by Acadian Asset Management LLCmarketbeat.com - March 6 at 5:17 AMC4 Therapeutics to Present New Preclinical Data on Highly Selective Orally Bioavailable BiDAC™ Degraders at the American Association for Cancer Research Annual Meeting 2024globenewswire.com - March 5 at 4:30 PMC4 Therapeutics, Inc. (NASDAQ:CCCC) Short Interest Updatemarketbeat.com - March 5 at 7:49 AMC4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteinsglobenewswire.com - March 4 at 7:00 AMCCCC Mar 2024 9.000 callfinance.yahoo.com - March 2 at 12:04 AMC4 Therapeutics' TORPEDO Platform Is Promising, But Its Valuation Remains Stretchedseekingalpha.com - March 1 at 4:10 PMC4 Therapeutics (NASDAQ:CCCC) Hits New 12-Month High at $10.83marketbeat.com - February 28 at 11:29 AMNew Forecasts: Here's What Analysts Think The Future Holds For C4 Therapeutics, Inc. (NASDAQ:CCCC)finance.yahoo.com - February 27 at 7:09 AMBreaking Down C4 Therapeutics: 4 Analysts Share Their Viewsmarkets.businessinsider.com - February 26 at 9:07 PMC4 Therapeutics (NASDAQ:CCCC) Given New $8.00 Price Target at Morgan Stanleymarketbeat.com - February 26 at 11:20 AMCCCC Mar 2024 8.500 putfinance.yahoo.com - February 25 at 5:33 PMCCCC Mar 2024 7.000 putca.finance.yahoo.com - February 24 at 10:25 PMC4 Therapeutics Full Year 2023 Earnings: Misses Expectationsfinance.yahoo.com - February 24 at 12:24 PMStrong Financials and Promising Drug Pipeline Bolster Buy Rating for C4 Therapeuticsmarkets.businessinsider.com - February 23 at 4:16 PMC4 Therapeutics price target raised by $1 at Stifel, here's whyrealmoney.thestreet.com - February 23 at 9:48 AMC4 Therapeutics (NASDAQ:CCCC) Earns Buy Rating from Stifel Nicolausmarketbeat.com - February 23 at 9:29 AMC4 Therapeutics Stock (NASDAQ:CCCC) Insider Tradesbenzinga.com - February 22 at 5:34 PMC4 Therapeutics, Inc.: C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlightsfinanznachrichten.de - February 22 at 12:34 PMC4 Therapeutics Inc (CCCC) Reports Full Year 2023 Financial Results and Business Updatesfinance.yahoo.com - February 22 at 12:34 PMC4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlightsfinance.yahoo.com - February 22 at 7:29 AMC4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlightsglobenewswire.com - February 22 at 7:00 AMCCCC Feb 2024 9.000 putfinance.yahoo.com - February 17 at 9:20 AMC4 Therapeutics, Inc. (CCCC) May Report Negative Earnings: Know the Trend Ahead of Q4 Releasefinance.yahoo.com - February 15 at 1:00 PMC4 Therapeutics (CCCC) to Report Q4 Earnings: What's in Store?finance.yahoo.com - February 15 at 1:00 PM Get C4 Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CCCC and its competitors with MarketBeat's FREE daily newsletter. Email Address The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him CCCC Media Mentions By Week CCCC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CCCC News Sentiment▼0.350.39▲Average Medical News Sentiment CCCC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CCCC Articles This Week▼82▲CCCC Articles Average Week Get C4 Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CCCC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Editas Medicine News Today Voyager Therapeutics News Today Fate Therapeutics News Today Lexeo Therapeutics News Today Taysha Gene Therapies News Today Tourmaline Bio News Today Humacyte News Today Allogene Therapeutics News Today ProKidney News Today Replimune Group News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CCCC) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersProof that the Musk/Bezos rivalry is about to hit a new levelInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding C4 Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
